クモ膜嚢腫治療の世界市場

クモ膜嚢腫治療の世界市場は2030年までに17億米ドルに達する

2024年に13億米ドルと推定されるクモ膜嚢腫治療の世界市場は、2030年には17億米ドルに達し、分析期間2024-2030年のCAGRは3.8%で成長すると予測されます。本レポートで分析したセグメントの1つである頭蓋内くも膜嚢腫は、CAGR 3.1％を記録し、分析期間終了までに11億米ドルに達すると予測されます。脊髄くも膜嚢腫セグメントの成長率は、分析期間中CAGR 5.2％と推定されます。

米国市場は3億6,320万米ドルと推定、中国はCAGR6.9％で成長予測

米国のクモ膜嚢腫治療市場は、2024年に3億6,320万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR6.9%を牽引し、2030年には予測市場規模3億3,380万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.6%と2.9%と予測されています。欧州では、ドイツがCAGR 2.2%で成長すると予測されています。

世界のクモ膜嚢腫治療市場- 主要動向と促進要因まとめ

くも膜嚢胞とは何か？

クモ膜嚢胞は、脳や脊髄と、中枢神経系を囲む3つの保護層の1つであるクモ膜との間に発生する液体で満たされた嚢胞です。これらの嚢胞は先天性のことが多いのですが、外傷や感染症、脳手術の合併症によって生じることもあります。くも膜嚢胞の多くは無症状のままであり、画像検査で偶然発見されるが、有症状の場合は頭痛、めまい、痙攣、水頭症、認知障害などの神経学的合併症を引き起こす可能性があります。磁気共鳴画像法（MRI）、コンピュータ断層撮影法（CT）、脳脊髄液流検査などの画像診断技術の進歩により、くも膜嚢胞の発見と特徴付けが著しく改善されました。また、高解像度の画像診断ツールの利用が可能になったことで、早期診断と治療計画が可能になり、長期的な合併症のリスクが減少しました。さらに、人工知能（AI）を搭載した放射線診断ソリューションは、嚢胞分類の精度を向上させ、症候性嚢胞と偶発性嚢胞の鑑別を可能にしています。ヘルスケアプロバイダーが診断プロトコルを改良し続けるにつれて、くも膜嚢胞の管理において、治療決定の指針となる精密画像の役割はますます重要になってきています。

クモ膜嚢腫治療における外科的、非外科的アプローチはどのように進化しているか？

くも膜嚢胞の治療は、症状の重症度、嚢胞の大きさ、部位によって異なります。無症状の嚢胞は介入を必要としないことが多いが、症状のある症例では非外科的管理または外科的処置のいずれかが必要となります。軽症例では、鎮痛薬、抗痙攣薬、コルチコステロイドなどの薬理学的治療が症状管理によく用いられます。しかし、進行性の神経障害、水頭症、頭蓋内圧亢進がみられる患者に対しては、外科的治療が必要となることが多いです。脳神経外科技術の進歩はくも膜嚢胞の治療に革命をもたらし、内視鏡的柵状切除術、膀胱腹腔シャント術、マイクロサージャリー切除術などの低侵襲手術が脚光を浴びています。特に内視鏡的柵状切除術は、合併症リスクの軽減、回復時間の短縮、術後成績の改善により、好ましいアプローチとして台頭してきました。さらに、術中の神経ナビゲーションとリアルタイム画像の統合により、手術精度が向上し、周囲の脳構造へのダメージが最小限に抑えられています。ロボット支援脳外科手術の採用が拡大していることで、器用さ、手術時間の短縮、患者の安全性の向上がもたらされ、治療方法がさらに変化しています。手術の技術革新が進化を続ける中、脳神経外科医は、くも膜嚢胞患者の転帰を最適化するために、個別化されたアプローチを採用するようになってきています。

どのような市場動向がクモ膜嚢腫治療の需要に影響を与えているか？

神経疾患の発生率の上昇、神経外科研究への投資の増加、精密医療の進歩など、いくつかの市場動向がくも膜嚢胞治療の需要を形成しています。てんかん、水頭症、外傷性脳損傷などの神経疾患の世界の流行により、くも膜嚢胞の早期介入と高度な治療戦略への注目が高まっています。その他の特典として、神経内科と脳神経外科の専門センターの拡大により、質の高い治療へのアクセスが改善され、より多くの患者が最先端の治療法の恩恵を受けることができるようになりました。また、患者中心のヘルスケアに重きが置かれるようになったことで、非侵襲的・低侵襲的な治療アプローチに対する需要も高まっており、医療機器メーカーは革新的な手術器具や神経ナビゲーションシステムの開発を促しています。さらに、神経外科手術計画におけるAIと機械学習の統合は、予測分析とリアルタイムの意思決定を可能にすることで、治療成果を最適化しています。神経学的健康に対する意識の高まりと医療技術の進歩により、くも膜嚢胞治療の状況は、患者と医療提供者のニーズを満たすために急速に進化しています。

クモ膜嚢腫治療市場を促進する主な成長要因は？

くも膜嚢胞治療市場の成長は、神経外科手術の技術的進歩、AIを活用した診断法の採用の高まり、低侵襲治療に対する患者の嗜好の高まりなど、いくつかの要因によって牽引されています。内視鏡およびロボット支援脳神経外科手術の継続的な開発により、治療効果が向上し、手術リスクが低減し、回復時間が改善されています。さらに、遠隔医療や遠隔診察サービスの利用が可能になりつつあることで、特にヘルスケアインフラが限られている地域では、脳神経外科の専門知識へのアクセスが拡大しています。また、医療費の増加や神経学研究に対する政府の資金援助も、新たな治療戦略や次世代医療機器の開発を支援し、市場拡大に拍車をかけています。さらに、製薬会社、医療技術企業、研究機関の協力関係の高まりは、くも膜嚢胞管理のための革新的な治療法の開発を加速させています。精密医療と個別化された治療計画への需要が高まり続ける中、医療の進歩、進化するヘルスケア政策、患者の転帰改善への注目の高まりによって、くも膜嚢胞治療市場は持続的な成長が見込まれます。

セグメント

タイプ（頭蓋内くも膜嚢胞、脊髄くも膜嚢胞）、診断（CTスキャン、MRIスキャン、出生前超音波検査、その他の診断）、治療タイプ（内視鏡嚢胞フェネストレーション、フェネストレーション、永久ドレナージシステム手術）、エンドユーザー（病院エンドユーザー、外来手術センターエンドユーザー、その他のエンドユーザー）

調査対象企業の例

• Abbott Laboratories
• Accuray Incorporated
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Elekta AB
• GE Healthcare
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson
• Karl Storz SE & Co. KG
• Medtronic plc
• Novartis AG
• Olympus Corporation
• Penumbra, Inc.
• Pfizer Inc.
• Philips Healthcare
• Siemens Healthineers AG
• Stryker Corporation
• Terumo Corporation
• Varian Medical Systems, Inc.
• Zimmer Biomet Holdings, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Arachnoid Cysts Treatment Market to Reach US$1.7 Billion by 2030

The global market for Arachnoid Cysts Treatment estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Intracranial Arachnoid Cysts, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Spinal Arachnoid Cysts segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$363.2 Million While China is Forecast to Grow at 6.9% CAGR

The Arachnoid Cysts Treatment market in the U.S. is estimated at US$363.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$333.8 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Arachnoid Cysts Treatment Market - Key Trends & Drivers Summarized

What Are Arachnoid Cysts and How Are They Diagnosed?

Arachnoid cysts are fluid-filled sacs that develop between the brain or spinal cord and the arachnoid membrane, one of the three protective layers surrounding the central nervous system. These cysts are often congenital but can also arise due to trauma, infections, or complications from brain surgeries. While many arachnoid cysts remain asymptomatic and are discovered incidentally during imaging tests, symptomatic cases can lead to neurological complications, including headaches, dizziness, seizures, hydrocephalus, and cognitive impairment. Advances in diagnostic imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT) scans, and cerebrospinal fluid flow studies have significantly improved the detection and characterization of arachnoid cysts. The increasing availability of high-resolution imaging tools has also enabled early diagnosis and treatment planning, reducing the risk of long-term complications. Furthermore, artificial intelligence (AI)-powered radiology solutions are enhancing the accuracy of cyst classification, allowing for better differentiation between symptomatic and incidental cysts. As healthcare providers continue to refine diagnostic protocols, the role of precision imaging in guiding treatment decisions is becoming increasingly critical in the management of arachnoid cysts.

How Are Surgical and Non-Surgical Approaches Evolving in Arachnoid Cyst Treatment?

The treatment of arachnoid cysts varies based on the severity of symptoms, cyst size, and location. While asymptomatic cysts often require no intervention, symptomatic cases may necessitate either non-surgical management or surgical procedures. Pharmacological treatments, including pain relievers, anti-seizure medications, and corticosteroids, are commonly used for symptom management in mild cases. However, for patients experiencing progressive neurological deficits, hydrocephalus, or increased intracranial pressure, surgical intervention is often required. Advances in neurosurgical techniques have revolutionized the treatment of arachnoid cysts, with minimally invasive procedures such as endoscopic fenestration, cystoperitoneal shunting, and microsurgical resection gaining prominence. Endoscopic fenestration, in particular, has emerged as a preferred approach due to its reduced risk of complications, shorter recovery times, and improved postoperative outcomes. Additionally, the integration of intraoperative neuro-navigation and real-time imaging has enhanced surgical precision, minimizing damage to surrounding brain structures. The growing adoption of robotic-assisted neurosurgery is further transforming treatment modalities, offering greater dexterity, reduced operative time, and enhanced patient safety. As surgical innovations continue to evolve, neurosurgeons are increasingly adopting personalized approaches to optimize outcomes for patients with arachnoid cysts.

What Market Trends Are Influencing the Demand for Arachnoid Cyst Treatments?

Several market trends are shaping the demand for arachnoid cyst treatments, including the rising incidence of neurological disorders, increasing investments in neurosurgical research, and advancements in precision medicine. The global prevalence of neurological conditions such as epilepsy, hydrocephalus, and traumatic brain injuries has heightened the focus on early intervention and advanced treatment strategies for arachnoid cysts. Additionally, the expansion of specialized neurology and neurosurgery centers has improved access to high-quality care, enabling more patients to benefit from cutting-edge treatment options. The growing emphasis on patient-centric healthcare is also driving demand for non-invasive and minimally invasive therapeutic approaches, prompting medical device manufacturers to develop innovative surgical instruments and neuro-navigation systems. Furthermore, the integration of AI and machine learning in neurosurgical planning is optimizing treatment outcomes by enabling predictive analytics and real-time decision-making. With increasing awareness of neurological health and advancements in medical technology, the landscape of arachnoid cyst treatment is rapidly evolving to meet the needs of patients and healthcare providers alike.

What Are the Key Growth Drivers Fueling the Arachnoid Cyst Treatment Market?

The growth in the arachnoid cyst treatment market is driven by several factors, including technological advancements in neurosurgical procedures, the rising adoption of AI-powered diagnostics, and increasing patient preference for minimally invasive treatments. The continuous development of endoscopic and robotic-assisted neurosurgery is enhancing treatment efficacy, reducing surgical risks, and improving recovery times. Additionally, the increasing availability of telemedicine and remote consultation services is expanding access to neurosurgical expertise, particularly in regions with limited healthcare infrastructure. The rising healthcare expenditure and government funding for neurological research are also fueling market expansion by supporting the development of novel treatment strategies and next-generation medical devices. Furthermore, growing collaborations between pharmaceutical companies, medical technology firms, and research institutions are accelerating the development of innovative therapies for arachnoid cyst management. As the demand for precision medicine and personalized treatment plans continues to rise, the arachnoid cyst treatment market is expected to experience sustained growth, driven by medical advancements, evolving healthcare policies, and the increasing focus on improving patient outcomes.

SCOPE OF STUDY:

The report analyzes the Arachnoid Cysts Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Intracranial Arachnoid Cysts, Spinal Arachnoid Cysts); Diagnosis (CT Scan, MRI Scan, Prenatal Ultrasound, Other Diagnosis); Treatment Type (Endoscopic Cysts Fenestration, Fenestration, Permanent Drainage System Surgery); End-Use (Hospital End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

• Abbott Laboratories
• Accuray Incorporated
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Elekta AB
• GE Healthcare
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson
• Karl Storz SE & Co. KG
• Medtronic plc
• Novartis AG
• Olympus Corporation
• Penumbra, Inc.
• Pfizer Inc.
• Philips Healthcare
• Siemens Healthineers AG
• Stryker Corporation
• Terumo Corporation
• Varian Medical Systems, Inc.
• Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Arachnoid Cysts Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Detection of Incidental Brain Cysts Due to Increased MRI Usage Expands Diagnostic Rate for Arachnoid Cysts
  • Advancements in Neuroimaging Techniques Strengthen Accuracy in Arachnoid Cyst Localization and Characterization
  • Surge in Pediatric Neurology Referrals Throws the Spotlight on Early Intervention and Monitoring of Arachnoid Cysts
  • Increasing Adoption of Minimally Invasive Neurosurgical Techniques Drives Surgical Treatment Uptake
  • Growth in Neurosurgical Navigation and Real-Time Imaging Supports Safe Resection and Drainage Procedures
  • Rising Prevalence of Symptomatic Arachnoid Cysts With Neurological Deficits Fuels Therapeutic Intervention Demand
  • Expansion of Specialized Neurosurgical Centers and Pediatric Neurology Clinics Improves Access to Treatment
  • Increased Use of Endoscopic Fenestration Procedures Enhances Recovery Outcomes and Reduces Hospital Stay
  • Development of Biocompatible Shunt Systems Strengthens Business Case for CSF Diversion Therapies
  • Greater Awareness Among General Practitioners and Pediatricians Promotes Timely Referrals and Screening
  • Emerging Research Into Genetic and Developmental Causes Supports Long-Term Surveillance Protocols
  • Adoption of Personalized Neurosurgical Planning With 3D Imaging and Patient-Specific Simulations Improves Outcomes
  • Advancements in Intraoperative Monitoring and Brain Mapping Tools Enhance Surgical Precision
  • Improved Post-Surgical Rehabilitation Protocols Sustain Quality of Life Post-Treatment
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Arachnoid Cysts Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Arachnoid Cysts Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Arachnoid Cysts Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Intracranial Arachnoid Cysts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Intracranial Arachnoid Cysts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Intracranial Arachnoid Cysts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Spinal Arachnoid Cysts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Spinal Arachnoid Cysts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Spinal Arachnoid Cysts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for CT Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for MRI Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for MRI Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for MRI Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Prenatal Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Prenatal Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Prenatal Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Endoscopic Cysts Fenestration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Endoscopic Cysts Fenestration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Endoscopic Cysts Fenestration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Fenestration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Fenestration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Fenestration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Permanent Drainage System Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Permanent Drainage System Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Permanent Drainage System Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• JAPAN
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• CHINA
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 77: China Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• EUROPE
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Arachnoid Cysts Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Arachnoid Cysts Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• FRANCE
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 104: France Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• GERMANY
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 140: UK Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• INDIA
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 215: India Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Arachnoid Cysts Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Arachnoid Cysts Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
• AFRICA
  • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030

IV. COMPETITION